- Aristo Pharma Iberia begins the commercialization of PolyHeal Micro in Spain
- PolyHeal® Micro is an innovative product with a unique microsphere technology, indicated for the treatment of hard to heal wounds.
Madrid, 11 de septiembre de 2019
Praxis Pharmaceutical reaches a distribution agreement for PolyHeal® Micro, an innovative product with a unique microsphere technology, indicated for the treatment of hard to heal wounds, with Aristo Pharma Iberia in Spain.
Last July, Praxis Pharmaceutical, a company specialized in the commercial development of products for the advanced treatment of chronic wounds, and Aristo Pharma Iberia, a pharmaceutical company belonging to the German group Aristo Pharma GmbH, signed an agreement for the commercialization of PolyHeal® Micro in Spain. The objective of this alliance is to establish a collaboration that provides healthcare professionals specialized in advanced wound treatment, knowledge, clinical support and the necessary resources.
Juan José Jiménez, General Director of Aristo, affirms that from Aristo Pharma Iberia they start with great enthusiasm “a new journey by Praxis Pharmaceutical in the field of wound healing”. With this strategic alliance, they are confident that the commercialization of this innovative product by the Hospitals Division will culminate in a successful project for all.
Both companies share the same purpose: to bet on innovation and to improve the health and quality of life of patients. In this sense, Aristo Pharma will contribute with its extensive experience in the hospital field for the launch of Polyheal® Micro, which will represent a great market opportunity. In addition, Jiménez points out that the “objective is always to promote innovation and development in the sector, so that we will be the perfect commercial complement for Praxis, which will provide us with specialized advice and support in a new therapeutic area for Aristo.”
Aitor Madina, CEO of Praxis Pharmaceutical, points out that “the alliance of Praxis and Aristo will allow Spanish healthcare professionals to have this new product within the therapeutic arsenal for wound healing. ”In his opinion, “patients will be able to benefit from its proven results, characterized by its remarkable efficacy even in wounds with exposed bone and tendon.”
The agreement is part of Praxis Pharmaceutical’s strategy of expansion and internalization of Polyheal® Micro through specialized commercial partners. Its expansion engine is collaboration, contributing with knowledge and resources from the beginning of the alliance.
About Praxis Pharmaceutical
Praxis Pharmaceutical is a company specialized in the commercial development of pharmaceutical products and medical devices for the advanced treatment of chronic wounds, based in Madrid (Spain).
Founded in 2006, Praxis began its internationalization in the year 2012. Today, we have a direct presence with commercial headquarters in Madrid and Bogotá.
At Praxis Pharmaceutical we are committed to the internationalization of PolyHeal® Micro as one of our drivers for long-term growth. Proof of this are our alliances with business partners to open new markets and have a presence in 5 continents.
About Aristo Pharma Iberia
Aristo Pharma Iberia is a Spanish company belonging to the dynamic and growing group of Aristo Pharma GmbH based in Berlin, Germany. It has an outstanding team. At Aristo we have various lines of business, from pharmacy office to hospitals. Our commitment is focused on the well-being and health of people.